These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 2184042)

  • 1. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Ichikawa J; Meltzer HY
    Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry.
    Maidment NT; Marsden CA
    Neuropharmacology; 1987; 26(2-3):187-93. PubMed ID: 2438582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
    Chai B; Meltzer HY
    Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    Moghaddam B; Bunney BS
    J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
    Lane RF; Blaha CD; Rivet JM
    Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine release in n. accumbens and striatum by clozapine: simultaneous monitoring by in vivo electrochemistry.
    Huff RM; Adams RN
    Neuropharmacology; 1980 Jun; 19(6):587-90. PubMed ID: 7402448
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of haloperidol and clozapine on (+)SKF 10,047-induced dopamine release: role of 5-HT3 receptors.
    Volonté M; Ceci A; Borsini F
    Eur J Pharmacol; 1992 Mar; 213(1):163-4. PubMed ID: 1499654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.
    Salin P; Mercugliano M; Chesselet MF
    Cell Mol Neurobiol; 1990 Mar; 10(1):127-44. PubMed ID: 1970756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.